RNAZ
Transcode Therapeutics Inc
NASDAQ: RNAZ · HEALTHCARE · BIOTECHNOLOGY
$8.01
-4.64% today
Updated 2026-04-30
Market cap
$7.75M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-52.59
Dividend yield
—
52W range
$6 – $22
Volume
0.0M
Transcode Therapeutics Inc (RNAZ) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-299572.00 | $-508508.00 | $-492971.00 | $-5.27M | $-15.76M | $-18.07M | $-13.34M | $-19.52M |
| Capital expenditures | $254820.00 | $254820.00 | $254820.00 | $254820.00 | $100918.00 | $35609.00 | $21761.00 | $6660.00 |
| Depreciation | $42470.00 | $42470.00 | $42470.00 | $42470.00 | $98606.00 | $516746.00 | $534857.00 | — |
| Stock-based comp | $22379.00 | $1397.00 | $45444.00 | $185996.00 | $395329.00 | $1.04M | $1.70M | $485428.00 |
| Free cash flow | $-554392.00 | $-763328.00 | $-747791.00 | $-5.52M | $-15.86M | $-18.11M | $-13.36M | $-19.52M |
| Investing cash flow | $-251820.00 | $-251820.00 | $-251820.00 | $-251820.00 | $-100919.00 | $-35609.00 | $-21761.00 | — |
| Financing cash flow | $512431.00 | $500000.00 | $1.12M | $25.52M | $5989.00 | $15.91M | $16.40M | — |
| Dividends paid | — | — | — | — | — | — | $30.60M | $1.61B |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — |